DATA. DEVICE. DETECTION.

 

A journey to combat neurodegenerative diseases.

 

 

About Us

The Sunita Sanghi Centre of Aging and Neurodegenerative Diseases (SCAN) at IIT Bombay was established in February 2022, to advance the knowledge of aging and neurodegeneration, which affects millions of people worldwide.

Our main objective is to understand the molecular and pathological basis of disease mechanisms and develop innovative therapeutics/tools against neurodegenerative disorders such as Parkinson’s, Alzheimer’s, and Frontotemporal Dementia (FTD).

“The world is witnessing an unprecedented surge in aging populations, presenting profound public health challenges and unparalleled opportunities for innovation and resilience. At the SCAN Centre, we are driven by a bold vision to unravel the complexities of neurodegenerative diseases and create pathways toward healthier, more vibrant lives for people of all ages.

Through pioneering research, early diagnostic breakthroughs, and dynamic collaborations, we aim to transform the narrative of aging—turning its challenges into powerful catalysts for growth and societal progress. Mr. Sharad Sanghi’s extraordinary generosity has made this transformative mission possible. His unwavering support empowers us to lead groundbreaking advancements, offering millions worldwide hope and a brighter future.”

Prof. Shireesh B Kedare

IITB Director

“As the Indian population ages and its growth slows down, the burden of neurodegenerative diseases will increase. Early detection and slowing the onset of such diseases will be key levers towards effective therapy, and this Centre will go a long way in helping us overcome this challenge. Mr. Sanghi’s donation will enable us to embark on this journey and we are deeply grateful to him for his generosity.”

Prof. Subhasis Chaudhuri

Previous IITB Director

Focus Areas

  • Early detection of diseases caused due to aging and neurodegenerative diseases such as Parkinson’s (PD), Alzheimer’s (AD) and Frontotemporal dementia (FTD).
  • Creating biological age profiles (normal aging versus aging-related disorders such as PD and AD) using blood samples.
  • Understanding the molecular mechanisms and development of therapeutics & tools against neurodegenerative disorders such as PD, AD and FTD.
  • Movement support - Assisted support for aging & neurodegenerative patients.

Research

Understanding Disease Mechanism

Deciphering the molecular, cellular, and biochemical mechanism of disease onset and progression using a wide range of disease-relevant in vitro, cell-based and computational studies.

Read More

Diagnosis

Developing novel tools and biomarkers for the early detection, diagnosis, and prognosis of neurodegenerative disorders, such as Parkinson’s disease, Alzheimer’s disease, and Frontotemporal dementia.

Read More

Diagnosis

Developing novel tools and biomarkers for the early detection, diagnosis, and prognosis of neurodegenerative disorders, such as Parkinson’s disease, Alzheimer’s disease, and Frontotemporal dementia.

Read More

Devices & Policy

Providing adaptive equipment and assistive technologies for movement support for Aging / neurodegenerative patients.

Read More

Resources

The SCAN centre will focus on following neurodegenerative diseases: Alzheimer’s, Parkinson’s, and Frontotemporal dementia

Alzheimer’s Disease
Parkinson’s Disease
Frontotemporal Dementia

News and Updates

Event Organized

SCAN Symposium 2025

The Sunita Sanghi Centre of Aging and Neurodegenerative Diseases (SCAN Centre), IIT Bombay, held its Annual Symposium on 9–10 January 2026 to mark its third anniversary, themed *“Neurodegenerative Disorders in India: Current Practices and Challenges.”* The symposium was inaugurated by the Director, IIT Bombay, Prof. Shireesh Kedare, with addresses from the Deans, Prof. Sachin C. Patwardhan and Prof. Upendra V. Bhandarkar, and Mr. Sharad Sanghi. Prof. Samir K. Maji, Professor-in-Charge of SCAN, presented an overview of the Centre and its research initiatives. The event brought together clinicians and researchers to discuss advances and challenges in disorders such as Parkinson’s disease, Alzheimer’s dementia, and epilepsy, highlighting early diagnosis, biomarkers, imaging, and emerging technologies including AI. The symposium fostered interdisciplinary collaboration through talks, posters, and discussions, while also engaging caregivers and families, reinforcing SCAN’s commitment to advancing research and clinical care in neurodegenerative diseases in India. KNOW MORE >>

Twitter

Read More

SCAN Event Schedule

error: